Ledger.Open graph →
SEC Form D · filed January 10, 2024

Relay Therapeutics, Inc

Offering
$30.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Laura S. Shawver · CAMBRIDGE, MADirectorDonald A. Bergstrom · CAMBRIDGE, MAExecAlexis A. Borisy · Redwood City, CADirectorDouglas S. Ingram · CAMBRIDGE, MADirectorThomas A. Catinazzo · CAMBRIDGE, MAExecPeter A. Rahmer · CAMBRIDGE, MAExecSekar S. Kathiresan · CAMBRIDGE, MADirectorSanjiv K. Patel · CAMBRIDGE, MAExec · DirectorMark S. Murcko · CAMBRIDGE, MADirectorBrian K. Adams · Glen Mills, PAExecLinda A. Hill · CAMBRIDGE, MADirectorJami S. Rubin · CAMBRIDGE, MADirectorThomas A. Catinazzo · CAMBRIDGE, MAExecPeter A. Rahmer · CAMBRIDGE, MAExecSekar S. Kathiresan · CAMBRIDGE, MADirectorDouglas S. Ingram · CAMBRIDGE, MADirectorSanjiv K. Patel · CAMBRIDGE, MAExec · DirectorMark S. Murcko · CAMBRIDGE, MADirectorLaura S. Shawver · CAMBRIDGE, MADirectorBrian K. Adams · Glen Mills, PAExecLinda A. Hill · CAMBRIDGE, MADirectorJami S. Rubin · CAMBRIDGE, MADirectorDonald A. Bergstrom · CAMBRIDGE, MAExecAlexis A. Borisy · Watertown, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗